Clinical Trials Logo

Clinical Trial Summary

to Assess the Pharmacokinetic Properties of VeraCeptâ„¢ Intrauterine Contraceptive vs ParaGard® in Healthy, Post- Menarcheal Women


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03785366
Study type Interventional
Source Sebela Pharmaceuticals Inc.
Contact
Status Active, not recruiting
Phase Phase 3
Start date December 17, 2018
Completion date December 30, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04457076 - Evaluation of the Efficacy, Safety, and Tolerability of LevoCept Phase 3
Active, not recruiting NCT03633799 - Evaluation of Efficacy, Safety and Tolerability of VeraCept IUD Phase 3